ClinicaliQ Trial Snapshot
- Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence — Recruiting • NCT07499258.
- A study tracking how well Axonics rechargeable nerve stimulators work for bowel incontinence in routine clinical practice.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20. Conditions: Fecal Incontinence Interventions: Axonics SNM System INS Model 5101 (R20) Lead Sponsor: Axonics, Inc. Planned Enrollment: 55 participants